Tables

TABLE 1 PATENT EXPIRATION OF RESPIRATORY DRUGS 28
TABLE 2 BACTERIAL CONJUNCTIVITES DRUGS MARKET REVENUE BY DRUG CLASS' 2017-2024 ($MILLION) 32
TABLE 3 BACTERIAL CONJUNCTIVITIS DRUGS MARKET REVENUE BY REGIONS' 2017-2024 ($MILLION) 37
TABLE 4 POPULATION LIVING IN ENDEMIC AREAS OF TRACHOMA BY COUNTRY 42
TABLE 5 NOVARTIS AG: OFFERINGS 46
TABLE 6 NOVARTIS AG: RECENT DEVELOPMENTS 47
TABLE 7 VALEANT PHARMACEUTICALS INTERNATIONAL INC.: OFFERINGS 54
TABLE 8 VALEANT PHARMACEUTICALS INTERNATIONAL INC.: RECENT DEVELOPMENTS 54
TABLE 9 TEVA PHARMACEUTICAL INDUSTRIES LTD: PRODUCT OFFERINGS 59
TABLE 10 TEVA PHARMACEUTICAL INDUSTRIES LTD: RECENT DEVELOPMENTS 59
TABLE 11 AKORN INC: OFFERINGS 64
TABLE 12 AKRON INC.: RECENT DEVELOPMENTS 65
TABLE 13 SANTEN PHARMACEUTICAL CO.' LTD.: OVERVIEW 69
TABLE 14 SANTEN PHARMACEUTICAL CO.' LTD.: RECENT DEVELOPMENTS 69
TABLE 15 PERRIGO COMPANY PLC: OVERVIEW 70
TABLE 16 PERRIGO COMPANY PLC: RECENT DEVELOPMENTS 70
TABLE 17 MERCK & CO: OVERVIEW 71
TABLE 18 MERCK & CO: RECENT DEVELOPMENTS 71
TABLE 19 PFIZER: RECENT DEVELOPMENTS 73
TABLE 20 DAIICHI SANKYO' INC.: RECENT DEVELOPMENTS 74
TABLE 21 BAYER AG: OVERVIEW 75
TABLE 22 BAYER AG: RECENT DEVELOPMENTS 75
TABLE 23 F. HOFFMANN-LA ROCHE: OVERVIEW 76
TABLE 24 F. HOFFMANN-LA ROCHE: RECENT DEVELOPMENTS 76

?

LIST OF FIGURE

Charts

CHART 1 GLOBAL PHARMACEUTICAL R&D SPENDING (2010-2016) 9
CHART 2 R&D INVESTMENT BY TOP 10 COMPANIES ($BN) 10
CHART 3 PHARMACEUTICAL DRUGS BY SALES' 2017 12
CHART 4 CAUSES OF SIGHT LOSS GLOBALLY 13
CHART 5 RESEARCH METHODOLOGY OF GLOBAL BACTERIAL CONJUNCTIVITIS DRUGS MARKET 16
CHART 6 GLOBAL BACTERIAL CONJUCTIVITIS DRUGS MARKET REVENUE' 2017-2024 ($MILLION) 19
CHART 7 OVERVIEW OF GLOBAL CONTACT LENSES USER STATISTICS 20
CHART 8 SEGMENTATION OF GLOBAL BACTERIAL CONJUNCTIVITIS DRUGS MARKET 23
CHART 9 PORTER 5 FORCES OF BACTERIAL CONJUNCTIVITIS DRUGS MARKET 24
CHART 10 PEST ANALYSIS OF BACTERIAL CONJUNCTIVITIS DRUGS MARKET 25
CHART 11 MARKET DYNAMICS - DRO ANALYSIS 26
CHART 12 DRO - IMPACT ANALYSIS OF GLOBAL BACTERIAL CONJUCTIVITIS DRUGS MARKET 29
CHART 13 KEY STAKEHOLDERS 29
CHART 14 BACTERIAL CONJUNCTIVITES DRUGS MARKET BY APPLICATION SEGMENTATION' 2017 VS 2024 (%) 31
CHART 15 FLUOROQUINOLONES DRUGS MARKET REVENUE' 2017-2024 ($MILLION) 33
CHART 16 AMINOGLYCOSIDES DRUGS MARKET REVENUE' 2017-2024 ($MILLION) 34
CHART 17 MACROLIDES DRUGS MARKET REVENUE' 2017-2024 ($MILLION) 34
CHART 18 OTHER BACTERIAL CONJUNCTIVITIS DRUGS MARKET REVENUE' 2017-2024 ($MILLION) 35
CHART 19 BACTERIAL CONJUCNTIVITIS DRUGS MARKET BY REGIONAL SEGMENTATION' 2017 VS 2024 (%) 37
CHART 20 BACTERIAL CONJUNCTIVITIS DRUGS MARKET REVENUE IN NORTH AMERICA' 2017-2024 ($MILLION) 38
CHART 21 BACTERIAL CONJUNCTIVITIS DRUGS MARKET REVENUE IN THE EUROPE REGION' 2017-2023 ($MILLION) 40
CHART 22 BACTERIAL CONJUNCTIVITIS DRUGS MARKET REVENUE IN THE APAC REGION' 2017-2024 ($MILLION) 41
CHART 23 BACTERIAL CONJUNCTIVITIS DRUGS MARKET REVENUE IN REST OF THE WORLD' 2017-2024 ($MILLION) 42
CHART 24 NOVARTIS AG: OVERVIEW SNAPSHOT 46
CHART 25 NOVARTIS AG: BUSINESS UNITS 51
CHART 26 NOVARTIS AG: GEOGRAPHICAL PRESENCE 51
CHART 27 NOVARTIS AG: SWOT ANALYSIS 52
CHART 28 VALEANT PHARMACEUTICALS INTERNATIONAL INC: OVERVIEW SNAPSHOT 55
CHART 29 VALEANT PHARMACEUTICALS INTERNATIONAL INC: BUSINESS UNITS 56
CHART 30 VALEANT PHARMACEUTICALS INTERNATIONAL INC.: GEOGRAPHICAL PRESENCE 57
CHART 31 VALEANT PHARMACEUTICALS INTERNATIONAL INC: SWOT ANALYSIS 58
CHART 32 TEVA PHARMACEUTICAL INDUSTRIES LTD: OVERVIEW SNAPSHOT 60
CHART 33 TEVA PHARMACEUTICAL INDUSTRIES LTD: BUSINESS UNITS 61
CHART 34 TEVA PHARMACEUTICAL INDUSTRIES LTD: GEOGRAPHICAL PRESENCE 62
CHART 35 TEVA PHARMACEUTICAL INDUSTRIES LTD: SWOT ANALYSIS 63
CHART 36 AKRON INC: OVERVIEW SNAPSHOT 65
CHART 37 AKRON INC.: BUSINESS UNITS 67
CHART 38 AKRON INC.: SWOT ANALYSIS 67